ABBVIE CDR (CAD HEDGED)ABBVIE CDR (CAD HEDGED)ABBVIE CDR (CAD HEDGED)

ABBVIE CDR (CAD HEDGED)

Brak transakcji
Zobacz na super wykresach

Obligacje ABBV

Poniżej znajduje się lista obligacji korporacyjnych ABBVIE CDR (CAD HEDGED). Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol
YTM %
Wolumen
Cena %
Kupon %
Termin zapadalności
Kwota niezapłacona
Wartość nominalna
Min. kw. nominału
Emitent
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
7,40%15 K79,63%4,85%2044-06-1565,23 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7,28%10 K79,20%4,75%2045-03-1553,51 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
7,27%20 K79,46%4,63%2042-10-0167,49 M USD1 000,00 USD2 000,00 USDActavis, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
7,17%600 K84,44%4,55%2035-03-15107,65 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
AA5QDALLERGAN FNDG 15/25
6,87%099,13%3,80%2025-03-15130,22 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
6,00%50 K89,00%3,20%2029-11-2162,52 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5,69%14,81 M85,13%4,25%2049-11-215,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5,65%088,36%4,45%2046-05-142 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,56%40 K91,64%4,63%2042-10-01389,22 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5,55%091,83%4,70%2045-05-142,7 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5,54%14,11 M89,71%4,40%2042-11-062,6 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,50%1,32 M93,54%4,88%2048-11-141,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,49%160 K92,92%4,75%2045-03-15827,09 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5,47%9,18 M88,31%4,05%2039-11-214 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,46%7,99 M100,48%5,50%2064-03-151,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,45%11,01 M94,34%4,85%2044-06-151,01 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,33%22,42 M100,77%5,40%2054-03-153 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,27%16,46 M100,77%5,35%2044-03-15750 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5,24%093,27%4,30%2036-05-141 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5,15%095,58%4,50%2035-05-142,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5,08%2,02 M96,40%4,55%2035-03-151,68 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4,91%6,94 M100,90%5,05%2034-03-153 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4,88%099,43%3,60%2025-05-143,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,79%52,04 M93,61%3,20%2029-11-215,44 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,70%16,97 M101,24%4,95%2031-03-152 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4,62%2,14 M99,76%3,80%2025-03-152,89 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4,61%19,58 M100,68%4,80%2029-03-152,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4,59%1,79 M97,01%2,95%2026-11-213,99 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4,59%098,11%3,20%2026-05-142 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4,52%4,35 M99,11%4,25%2028-11-141,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4,47%7,37 M100,69%4,80%2027-03-152,25 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
4,30%094,32%2,63%2028-11-1572,11 M EUR1 000,00 EUR100 000,00 EURAllergan Funding SCS
XXS162262122ALLERGAN FNDG 17/29
4,11%092,45%2,13%2029-06-0136,46 M EUR1 000,00 EUR100 000,00 EURAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
3,86%096,53%2,95%2026-11-219,24 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
3,01%0102,15%3,80%2025-03-151,27 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABGABBVIE 19/31
2,94%090,23%1,25%2031-11-18650 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
2,90%0121,31%4,25%2049-11-214,95 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
2,88%0126,76%4,75%2045-03-155 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2,83%0128,71%4,85%2044-06-15100 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
XS152090781ABBVIE 16/28
2,76%097,72%2,13%2028-11-17750 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2,69%099,75%2,63%2028-11-15427,79 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2,68%097,76%2,13%2029-06-01506,09 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2,52%095,10%0,75%2027-11-18750 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,35%0123,74%4,55%2035-03-151 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
4,40%2042-11-061,1 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
3,80%2025-03-151 000,00 USD2 000,00 USDAbbVie, Inc.